Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer

NCT02124317 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: nanoparticle albumin-bound paclitaxel
DRUG: S-1

Sponsor

Chinese PLA General Hospital